High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$49K
$49,957
Total Sells (Filtered)
$600M
$600,050,778
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ROIV |
Roivant Sciences Ltd.
|
President
10b5-1 Sell
|
2026-02-23 | $16,159,099MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
Other
|
2026-02-23 | $2,261,452Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
10b5-1 Sell
|
2026-02-20 | $27,492,362MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
Other
|
2026-02-20 | $3,898,548Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
Other
|
2026-02-19 | $5,390,000Whale | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
10b5-1 Sell
|
2026-02-19 | $38,388,000MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2026-02-13 | $770,000 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -10.8%
|
2026-02-13 | $5,298,000Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2026-02-13
$3,994,268Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-13 | $3,994,268Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2026-02-13
$3,994,268Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-13 | $3,994,268Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2026-02-13 | $3,994,268Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2026-02-13 | $5,962,500Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2026-02-13
$5,962,500Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-13 | $5,962,500Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2026-02-13
$5,962,500Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-13 | $5,962,500Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2026-02-12 | $7,359,000Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2026-02-12 | $4,008,000Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2026-02-12
$7,359,000Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-12 | $7,359,000Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2026-02-12
$4,008,000Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-12 | $4,008,000Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2026-02-12
$7,359,000Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-12 | $7,359,000Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2026-02-12
$4,008,000Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-12 | $4,008,000Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2026-02-11 | $11,334,750MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2026-02-11
$11,334,750MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-11 | $11,334,750MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2026-02-11
$11,334,750MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-11 | $11,334,750MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Sukhatme Mayukh
• President
Discretionary Sell
2026-02-09
$8,985,003Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
President
Discretionary Sell
|
2026-02-09 | $8,985,003Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
Other
|
2026-02-09 | $8,261,755Whale | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -10.8%
|
2026-01-12 | $4,384,000Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2026-01-12 | $770,000 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2025-12-17 | $3,569,850Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2025-12-17 | $4,391,595Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2025-12-17
$3,569,850Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-17 | $3,569,850Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2025-12-17 | $9,974,150Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2025-12-17
$4,391,595Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-17 | $4,391,595Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
Other
|
2025-12-17 | $754,625 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
Discretionary Sell
|
2025-12-17 | $619,528 | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2025-12-17
$9,974,150Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-17 | $9,974,150Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2025-12-17
$4,391,595Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-17 | $4,391,595Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2025-12-17
$9,974,150Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-17 | $9,974,150Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2025-12-17
$3,569,850Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-17 | $3,569,850Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2025-12-16
$6,305,750Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-16 | $6,305,750Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2025-12-16
$14,823,869MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-16 | $14,823,869MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2025-12-16
$6,305,750Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-16 | $6,305,750Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2025-12-16
$14,823,869MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-16 | $14,823,869MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2025-12-16 | $14,823,869MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2025-12-16 | $6,305,750Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-12-15 | $17,291,855MEGA | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Other
|
2025-12-15 | $10,555,504MEGA | M | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Ramaswamy Vivek
• 10% Owner
Discretionary Sell
2025-12-15
$7,800,077Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Discretionary Sell
|
2025-12-15 | $7,800,077Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-12-15 | $950,430 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Discretionary Sell
|
2025-12-15 | $4,994,140Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Discretionary Sell
|
2025-12-15 | $12,273,395MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-12-15 | $28,819,763MEGA | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Discretionary Sell
|
2025-12-15 | $20,455,665MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Equity Compensation
|
2025-12-12 | $0 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Other
|
2025-12-12 | $59,250,140MEGA | M | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Ramaswamy Vivek
• 10% Owner
Discretionary Sell
2025-12-12
$43,389,842MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Discretionary Sell
|
2025-12-12 | $43,389,842MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Other
|
2025-12-11 | $23,707,682MEGA | M | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Ramaswamy Vivek
• 10% Owner
Discretionary Sell
2025-12-11
$16,752,433MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Discretionary Sell
|
2025-12-11 | $16,752,433MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -11.8%
|
2025-12-09 | $4,170,000Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-12-09 | $770,000 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Equity Compensation
|
2025-12-09 | $0 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2025-11-19 | $17,212,500MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2025-11-19 | $3,030,000Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2025-11-19 | $2,520,000Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2025-11-19 | $3,542,000Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2025-11-19
$17,212,500MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-11-19 | $17,212,500MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2025-11-19
$3,030,000Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-11-19 | $3,030,000Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2025-11-19
$2,520,000Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-11-19 | $2,520,000Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2025-11-19
$3,542,000Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-11-19 | $3,542,000Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2025-11-19
$3,542,000Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-11-19 | $3,542,000Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2025-11-19
$2,520,000Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-11-19 | $2,520,000Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2025-11-19
$3,030,000Large
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-11-19 | $3,030,000Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2025-11-19
$17,212,500MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-11-19 | $17,212,500MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Ramaswamy Vivek
• 10% Owner
Discretionary Sell
2025-11-17
$11,068,222MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Discretionary Sell
|
2025-11-17 | $11,068,222MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Ramaswamy Vivek
• 10% Owner
Discretionary Sell
2025-11-14
$20,892,531MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Discretionary Sell
|
2025-11-14 | $20,892,531MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Ramaswamy Vivek
• 10% Owner
Discretionary Sell
2025-11-13
$5,978,359Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Discretionary Sell
|
2025-11-13 | $5,978,359Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-11-07 | $770,000 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-11-07 | $4,044,000Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -11.7%
|
2025-11-07 | $4,044,000Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-10-17 | $2,020,211Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-17 | $1,876,925Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -17.5%
|
2025-10-16 | $5,426,708Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-16 | $5,044,770Whale | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -21.6%
|
2025-10-15 | $7,020,583Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-15 | $6,572,726Whale | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-10-13 | $336,814 | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-13 | $328,523 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-10-09 | $1,710,522Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-09 | $1,663,299Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-08 | $163,366 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-10-08 | $2,245,352Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-08 | $955,798 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -19.1%
|
2025-10-07 | $5,735,850Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-07 | $696,307 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-07 | $798,126 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-07 | $1,064,660Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-06 | $2,018,577Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -10.2%
|
2025-10-06 | $2,800,611Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-06 | $185,505 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-06 | $73,693 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -28.9%
|
2025-09-23 | $9,061,130Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-09-22 | $1,780,140Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-09-22 | $385,000 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -12.5%
|
2025-09-22 | $4,739,568Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-09-22 | $1,501,000Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-09-19 | $3,850,000Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -25.8%
|
2025-09-19 | $10,223,079MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Discretionary Buy
|
2025-09-18 | $49,957 | P | Form 4 |